Is hepcidin the star player in iron metabolism in chronic kidney disease?
- PMID: 19367309
- DOI: 10.1038/ki.2009.46
Is hepcidin the star player in iron metabolism in chronic kidney disease?
Abstract
It is well known that abnormal iron metabolism contributes to the development of anemia in chronic kidney disease (CKD) patients. Hepcidin is a circulating peptide produced in the liver that regulates efflux of iron from the cells. Ashby et al. measured the serum level of hepcidin using a new assay. Although the new assay produced mixed results and needs to be verified, these data suggest that hepcidin is not the only star player in iron metabolism in CKD.
Comment on
-
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.Kidney Int. 2009 May;75(9):976-81. doi: 10.1038/ki.2009.21. Epub 2009 Feb 11. Kidney Int. 2009. PMID: 19212416 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
